The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

This approach wouldn’t be suitable for perioral dermatitis or eczema as some foaming cleansers can dry the skin – a cream ...

People with eczema usually experience flare-ups during the winter season. During these periods, symptoms become worse and ...

Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It ...

Opens in a new tab or window Tapinarof 1% topical cream showed greater efficacy than the control in adults and children as young as age 2 years with atopic dermatitis (AD). The cream also provided ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with ...

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

Dermatitis. 2010;21(1):59-60 ... NJ), and three different topical clotrimazole creams, with no improvement. Several vaginal potassium hydroxide and wet preparations had negative results.